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Laparoscopic Liver Resection for Hepatocellular
Carcinoma
Carmen D. Chung, Lydia L. Lau, Kwan Lung Ko, Andrew C. Wong, Shezam Wong, Albert C. Chan, 
Ronnie T. Poon, Chung Mau Lo and Sheung Tat Fan, Department of Surgery, The University of Hong Kong, 
Hong Kong SAR.
OBJECTIVE: To provide an updated review on the clinical experience in laparoscopic liver resection,
specifically for hepatocellular carcinoma.
METHODS: A comprehensive literature search in MEDLINE was conducted for all English papers up to
May 2010 on laparoscopic liver resection for hepatocellular carcinoma. Patient characteristics, periopera-
tive results, and oncologic outcomes were compared and analysed.
RESULTS: We analysed 11 clinical studies involving 466 hepatocellular carcinoma patients treated with
laparoscopic hepatectomy. Thirty-seven (9%) patients underwent major resection. Cirrhosis occurred in
62%. The mean operative time was 189.5 min, and the mean blood loss was 315.6 mL. Blood transfusion
was required in 14.6% of patients. There were two operative deaths. Postoperative complications included bile
leakage (1%), bleeding (2.9%), liver failure (5.1%), and ascites (6%). The 1-year, 3-year, and 5-year disease-
free survival rates ranged from 60% to 90%, 50% to 64%, and 31% to 50%, respectively, and the corresponding
overall survival rates ranged from 85% to 100%, 67% to 100%, and 50% to 97% respectively.
CONCLUSION: Laparoscopic liver resection for hepatocellular carcinoma appears to be safe and to achieve
acceptable oncologic outcomes even in cirrhotic livers, but whether it is comparable to conventional open
surgery needs to be evaluated in a randomized, controlled trial setting. [Asian J Surg 2010;33(4):168–72]
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Introduction
Laparoscopic resection of liver tumours was first reported
in 1993.1 It was initially adopted to treat peripheral, benign
tumours amenable to nonanatomical wedge resection.
The relatively slow development of laparoscopic liver resec-
tion compared with that of other subspecialties of laparo-
scopic surgery can be attributed to several reasons. First,
some technical manoeuvres frequently applied in open liver
resection, such as organ mobilization, control of vascular
inflow, and hanging manoeuvres, are difficult to repro-
duce in the laparoscopic setting. Difficulty in controlling
haemorrhage, especially when profuse bleeding arises
from the inferior vena cava or occurs deep in the liver
parenchyma, is another major concern. Risk of gas
embolism secondary to pneumoperitoneum could lead to
dire consequences. In addition, increased risks of postop-
erative bile leakage and bleeding and uncertain long-term
oncologic outcomes concomitant with resection of malig-
nant tumours are all obstacles that have undermined the
development of laparoscopic hepatectomy.
With advancement in surgical instruments and increas-
ing experience in laparoscopic treatment for benign liver
diseases, there has been a growing interest in its application
for hepatocellular carcinoma (HCC). The Louisville consen-
sus statement2 concluded that left lateral sectionectomy
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should be performed routinely by the laparoscopic
approach. In the world review of over 2,000 laparoscopic
liver resections,1 postoperative morbidity and mortality
were shown to be comparable with those of open resec-
tion for both benign and malignant diseases. Nonetheless,
disease heterogeneity among these reviewed studies render
interpretation of surgical outcomes to specific indications
difficult. HCC is a common malignancy in the East Asia due
to the prevalence of hepatitis B infection. Cirrhosis is a
known risk factor for the development of HCC, and major
hepatectomy for cirrhotic livers could be technically chal-
lenging, even by an open approach. The aim of this article
was to review the global experience of laparoscopic resection
for HCC, especially in cirrhotic livers.
Patients and methods
A comprehensive literature search in MEDLINE using the
keywords “laparoscopic liver resection” and “hepatocellu-
lar carcinoma” was performed up to May 2010. English arti-
cles with human subjects were selected. Small series (i.e. <15
patients) and case reports were excluded. A total of 155 pub-
lications were identified. All papers were screened and appar-
ent duplicate data were excluded. Eleven papers3–13 with ≥15
patients per study were selected. Table 13–13 illustrates the
search results. Patient characteristics, perioperative results,
and oncologic outcomes were compared and analysed.
Results
The 11 selected papers covered 466 HCC patients 
who had undergone laparoscopic liver resection. Patient
characteristics are shown in Table 2.3–13 The mean age was
60 years. Of the 466 patients, 45% were hepatitis B carriers
and 62% had cirrhotic livers. Thirty-seven (9%) patients
had major laparoscopic liver resection (i.e. > 2 Couinaud
segments) and 372 (91%) had minor resection. The types
of laparoscopic resection for the remaining 57 patients
were not specified. Conversion to open resection was
required in 33 (7.7%) patients. The common reasons for
conversion included bleeding,4,7,8,12,13 slow progression,11
and inadequate resection margins.4
Intraoperative outcomes
More than half of the major resections were left (7/37) or
right (12/37) hemihepatectomies (Table 33–13). Central
bisectionectomy4 and trisectionectomy11 were seldom per-
formed. The mean operative time was 189.5 minutes. The
prolonged operative time in the studies by Yoon et al4
(281 min) and Dagher et al11 (231 min) was probably
attributed by the greater proportion of major hepatectomies
in their studies (13% and 15%, respectively). The mean
blood loss was 315.6 mL. None of the studies reported a
mean blood loss of over 1 L (103–808 mL). However, blood
transfusion was required in 14.6% of the cases (Table 43–13).
Postoperative outcomes
Mortality
There were two operative deaths among the 466 patients.
One death was due to severe respiratory distress syn-
drome, and the patient died 3 days after the operation.5
Another patient had Child-Pugh class C cirrhotic liver
and a partially ruptured HCC prior to surgery, and died
of liver failure.11
Table 1. Publications on laparoscopic liver resection for hepatocellular carcinoma3–13
Author Year Journal No. of patients Major resection Minor resection
Zhen et al3 2010 World Journal of Surgery 29 0 29
Yoon et al4 2009 Surgical Endoscopy 69 9 60
Belli et al5 2009 British Journal of Surgery 54 3 51
Sasaki et al6 2009 British Journal of Surgery 37 – –
Lai et al7 2009 World Journal of Surgery 30 1 29
Santambrogio et al8 2009 Langenbeck’s Archives of Surgery 22 0 22
Sarpel et al9 2009 Annals of Surgical Oncology 20 – –
Chen et al10 2008 Annals of Surgical Oncology 116 19 97
Dagher et al11 2008 Surgical Endoscopy 32 4 28
Cherqui et al12 2006 Annals of Surgery 27 1 26
Kaneko et al13 2005 American Journal of Surgery 30 0 30
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Morbidity
Morbidity was difficult to compare between the studies
because of the heterogenicity in the reporting methods.
However, we selected the clinically significant postopera-
tive morbidities (bile leakage, bleeding, liver failure, and
ascites) for analysis. The results are shown in Table 5.3–13
Postoperative bleeding occurred in 2.9% of the patients,
liver failure in 5.1%, ascites in 6%, and bile leakage in 1%.
The incidence of these postoperative morbidities appeared
to be comparable with those in open resections.14–16 After
open hepatectomy for cirrhotic livers, early formation of
ascites could leak through the healing wound, which is
psychologically disturbing to patients and could predis-
pose to wound infection. The adoption of laparoscopic
surgery would certainly minimize such negative effects of
ascites.
The average length of hospital stay was 9 days. How-
ever, length of hospital stay is not a reliable indicator of
postoperative outcome because it can differ across different
cultures and hospital policies. A better indicator would be
the time to resume a full diet, but this was only reported
in the Chen et al study,10 on postoperative days 2–3.
Table 2. Patient characteristics3–13
Author No. of patients
Country or Age Gender Hepatitis B 
region (M/F) virus positive
Cirrhosis
Zhen et al3 29 China 52.6 19/10 29 (100%) 16 (55%)
Yoon et al4 69 South Korea 56.5 50/19 53 (77%) 38 (55%)
Belli et al5 54 Italy 63.3 31/23 3 (6%) –
Sasaki et al6 37 Japan 66* – –
Lai et al7 30 Hong Kong SAR 58.1 22/8 28 (93%) 28 (93%)
Santambrogio et al8 22 Italy 61.4 13/9 2 (9%) –
Sarpel et al9 20 USA 63.8 15/5 – 9 (45%)
Chen et al10 116 Taiwan 58.3 92/24 74 (64%) –
Dagher et al11 32 France 65 22/10 2 (6%) 22 (69%)
Cherqui et al12 27 France 63 22/5 9 (33%) 20 (74%)
Kaneko et al13 30 Japan 59 18/12 4 (13%) 13 (43%)
Total 466 60 304/125 204 (45%) 146 (62%)
*The series included nonhepatocellular carcinoma patients and the age was averaged over all patients.
Table 3. Types of resection3–13
Author No. of patients Major
Left Right Central 
Trisectionectomy Minor
hepatectomy hepatectomy bisectionectomy
Zhen et al3 29 0 0 0 0 0 29
Yoon et al4 69 9 2 6 1 0 60
Belli et al5 54 3 – 2 – – 51
Sasaki et al6 37 – – – – – –
Lai et al7 30 1 0 1 0 0 29
Santambrogio et al8 22 0 0 0 0 0 22
Sarpel et al9 20 – – – – – –
Chen et al10 116 19 4 – – – 97
Dagher et al11 32 4 1 2 0 1 28
Cherqui et al12 27 1 0 1 0 0 26
Kaneko et al13 30 0 0 0 0 0 30
Total 466 37 (9%) 7 12 1 1 372 (91%)
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Oncologic outcomes and survival
Table 63–8,10–13 illustrates the long-term survival rates of
all selected studies. Tumour size ranged from 2.3 to
4.7 cm. Resection margin was reported in most of the
studies, but was usually quoted as > 1 cm; thus, there was
a lack of quantitative data to allow for comparison. The
average time for the development of tumour recurrence
ranged from 5 to 13 months. There was no incidence of
port site metastasis. The 1-year, 3-year, and 5-year disease-
free survival rates ranged from 60% to 90%, 50% to 64%, and
31% to 50%, respectively. The 1-year, 3-year, and 5-year
overall survival rates ranged from 85% to 100%, 67% to
100%, and 50% to 97%, respectively.
Conclusion
The future direction of laparoscopic liver resection will be
the use of surgical robotic systems.1,17,18 Cases of liver resec-
tion with the use of the Da Vinci robotic system have been
reported.19 Potential advantages of using robots include
visualization of high-quality three-dimensional images
and tremor-filtering. EndoWrist, a robotic instrument,
Table 4. Intraoperative results3–13
Author
No. of Operative time Blood loss Perioperative No. of 
patients (min) (mL) blood transfusion conversions
Zhen et al3 29 120 164 0 3
Yoon et al4 69 280.9 808.3 23 (33%) 5
Belli et al5 54 167 297 6 (11%) –
Sasaki et al6 37 195 103 – –
Lai et al7 30 139.4 200 3 (10%) 1
Santambrogio et al8 22 199 183 1 (5%) 3
Sarpel et al9 20 161 – – 0*
Chen et al10 116 156.2 138.9 8 (7%) 6
Dagher et al11 32 231 461 5 (16%) 3
Cherqui et al12 27 240 338 (n = 21), 5 (19%) 7
≥ 1,000 (n = 6)
Kaneko et al13 30 182 350 – 1
Total 466 189.5 315.6 14.6% 29
*There were four conversions from laparoscopic to open resection, but the four cases were excluded from the study results.
Table 5. Postoperative complications3–13
Author No. of patients Cirrhosis
Postoperative 
Liver failure Ascites Bile leakage
bleeding
Zhen et al3 29 16 (55%) 0 3 5 0
Yoon et al4 69 38 (55%) 2 – 4 2
Belli et al5 54 – 2 – 8 0
Sasaki et al6 37 – – – 1 –
Lai et al7 30 28 (93%) 1 0 – –
Santambrogio et al8 22 – 2 0 0 0
Sarpel et al9 20 9 (45%) – – – –
Chen et al10 116 – 0 – 2 0
Dagher et al11 32 22 (69%) 2 – 2 1
Cherqui et al12 27 20 (74%) 2 4 1 0
Kaneko et al13 30 13 (43%) – 0 – 1
Total 466 146 (62%) 11 (2.9%) 7 (5.1%) 23 (6%) 4 (1%)
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even provides a 360-degree range of motion. However, the
advantages of employing robotic systems must be bal-
anced with the entailed high cost of surgery, lack of train-
ing schemes, and difficulty of conversion to open surgery.
Nonetheless, the use of surgical robots is expected to
become more common in the treatment of both benign
and malignant liver tumours in the foreseeable future.
Laparoscopic liver resection has proven to be a safe
and feasible treatment option for HCC, even in cirrhotic
livers. Conversion, however, does not equate to failure. With
advances in surgical techniques and instruments, laparo-
scopic liver resection is performed more frequently, even
for tumours in difficult anatomical locations. Nonetheless,
oncologic clearance should not be jeopardized in exchange
for the postoperative benefits of laparoscopic surgery.
Although laparoscopic liver resection seems to achieve
acceptable long-term survival outcomes, whether it is
comparable to conventional open surgery must be evalu-
ated in a randomized, controlled trial setting.
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Table 6. Oncologic outcomes and survival rates3–8,10–13
Author
No. of Tumour Recurrence 1-year 1-year 3-year 3-year 5-year 5-year 
patients size (cm) (mo) OS DS OS DS OS DS
Zhen et al3 29 – – – – – – – –
Yoon et al4 69 3.1 11.6 (median) – – 90.4% 60.4% – –
Belli et al5 54 3.8 – 94% 78% 67% 52% – –
Sasaki et al6 37 2.5 – – – 73% – 53% –
Lai et al7 30 2.8 19.6 – – – – 50% 36%
Santambrogio et al8 22 2.86 – 85% 60% 75% 50% – –
Chen et al10 116 2.3 – 87% – 68% – 60% –
Dagher et al11 32 3.8 – – – 71.9% 54.5% – –
Cherqui et al12 27 – – – – 93% 64% – –
Kaneko et al13 30 3 – 97% 85% 78% 50% 61% 31%
OS = overall survival; DS = disease-free survival.
